COMMUNIQUÉS West-GlobeNewswire

UPDATE - Auxly Announces Receipt of Key Cannabis Oil Sales Licences for Dosecann and Kolab Project
09/09/2019
VANCOUVER, British Columbia, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") today announced that its wholly-owned subsidiaries, Dosecann Inc. (“ Dosecann ”) and [...]
NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disease and PATrOL™-Enabled Therapy on September 16th
09/09/2019
PITTSBURGH, Sept. 09, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing next-generation antisense therapies to address genetic diseases, [...]
Golden Leaf Holdings Expands Management Team
09/09/2019
Former Nike executive Stan Grissinger named President, Erin Hills promoted to Senior Vice President, Operations TORONTO, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden [...]
Zosano Pharma Announces the Presentation of Multiple Positive Datasets from the Qtrypta™ Long-Term Safety Study at the Congress of the International Headache Society
09/09/2019
- Repeated Dosing of Qtrypta Over the Course of One Year Reaffirms Qtrypta is Effective and Well-Tolerated as an Acute Treatment for Migraine - - Efficacy and Safety Profile Consistent in Sub Analyses of Patients Taking [...]
Orthogonal Thinker/EI Announces Kevin Matthews, Former Campaign Director of the Denver Psilocybin Initiative, to Join Senior Executive Team to Further Communications Strategy
09/09/2019
KIHEI, HAWAII, Sept. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Orthogonal Thinker Inc. (“Orthogonal/EI” or the “Company”), a biotech holding and operating company, announced today that Kevin Matthews has joined [...]
Assure Holdings Enters into First In-Network Agreement
09/09/2019
DENVER, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, entered into an agreement with a national [...]
Fluidigm Revolutionizes Next-Generation Sequencing RNA Library Preparation with Microfluidic Automation
09/09/2019
Fluidigm Launches Breakthrough RNA Sequencing Library Preparation Workflow, Delivering Substantial Cost Savings and Efficiency SOUTH SAN FRANCISCO, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ [...]
Mateon Partners With WideTrial for Data-Generating Expanded Access Programs in Cancer
09/09/2019
AGOURA HILLS, Calif. and SAN FRANCISCO, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics Inc. (OTCQB:MATN), announced today that it has executed agreements with WideTrial Inc. for an Expanded Access program (EAP) [...]
Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity
09/09/2019
LAVAL, Quebec, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST) a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Protech Home Medical Receives $8.6 Million
09/09/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE ‎UNITED STATES CINCINNATI, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“ Protech ” or the “ Company ”) (TSXV: ‎PTQ [...]
InspireMD Provides Business Update
09/09/2019
TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, [...]
Daré Bioscience Announces Completion of its Content Validity Study to Support the Continued Clinical Development of Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
09/09/2019
Sildenafil Cream, 3.6% has the Potential to Be the First FDA-Approved Product for FSAD SAN DIEGO, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, and [...]
Intercept Appoints Lisa DeFrancesco as Vice President, Investor Relations
09/09/2019
NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Ovid Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference
09/09/2019
NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]
BIOLIFE4D Becomes First U.S. Company to Successfully Demonstrate Ability to 3D Bioprint a Mini Human Heart
09/09/2019
Pioneering biotech company reaches significant milestone, using proprietary bioink to successfully 3D bioprint a mini-heart with full structure of a whole heart, including chambers and ventricles CHICAGO, Sept. 09, 2019 [...]
Synthorx to Present at the 2019 World Congress of Inflammation
09/09/2019
First-of-its-Kind Genetic Alphabet Platform Used to Design Synthorin for Autoimmune Indications SAN DIEGO, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company [...]
SubioMed to Attend American Orthopedic Foot and Ankle Society Annual Meeting in Chicago
09/09/2019
Largest Meeting of its Kind for Foot and Ankle Orthopedics Featuring World Class Companies Including Wright Medical, Depuy, Zimmer Bionet and Stryker MINNEAPOLIS, Sept. 09, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“ [...]
TYME Presents Positive Circulating Tumor Cell Data from TYME-88-Panc Study in Patients with Advanced Pancreatic Cancer at AACR PANC 2019
09/09/2019
TYME-88-PANC Phase II study showed patients being treated with SM-88, who achieved at least an 80% reduction in circulating tumor cell burden, demonstrated a 60% decrease in risk of death SM-88 is an oral, [...]
Harvard Bioscience Announces Strategic Action Plan and Financial Targets
09/09/2019
HOLLISTON, Mass., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announces its strategic action plan and financial targets for rest of year 2019 through 2021. Key strategic actions and [...]

Pages